GGRPX
Price
$8.79
Change
+$0.03 (+0.34%)
Updated
Jul 10 closing price
Net Assets
338.15M
JCCSX
Price
$7.82
Change
+$0.05 (+0.64%)
Updated
Jul 10 closing price
Net Assets
902.72M
Interact to see
Advertisement

GGRPX vs JCCSX

Header iconGGRPX vs JCCSX Comparison
Open Charts GGRPX vs JCCSXBanner chart's image
Goldman Sachs Commodity Strategy P
Price$8.79
Change+$0.03 (+0.34%)
VolumeN/A
Net Assets338.15M
ALPS/CorCmdty Mgmt CmpltCmdty Stra A
Price$7.82
Change+$0.05 (+0.64%)
VolumeN/A
Net Assets902.72M
GGRPX vs JCCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGRPX vs. JCCSX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRPX is a Hold and JCCSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JCCSX has more cash in the bank: 903M vs. GGRPX (338M). GGRPX pays higher dividends than JCCSX: GGRPX (3.20) vs JCCSX (2.57). GGRPX was incepted earlier than JCCSX: GGRPX (7 years) vs JCCSX (7 years). JCCSX (1.50) is less costly to investors than GGRPX (0.80). GGRPX has a lower initial minimum investment than JCCSX: GGRPX (0) vs JCCSX (2500). JCCSX annual gain was more profitable for investors over the last year : 7.44 vs. GGRPX (6.49). JCCSX return over 5 years is better than : 89.13 vs. GGRPX (81.59).
GGRPXJCCSXGGRPX / JCCSX
Total Expense Ratio0.611.4044%
Annual Report Gross Expense Ratio0.801.5053%
Fund Existence7 years7 years-
Gain YTD6.2919.90164%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets338M903M37%
Annual Yield % from dividends3.202.57125%
Returns for 1 year6.497.4487%
Returns for 3 years-1.573.46-45%
Returns for 5 years81.5989.1392%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AULRX83.21N/A
N/A
American Century Ultra® R
JIEMX19.66N/A
N/A
JHancock Equity Income 1
ICTEX16.62N/A
N/A
ICON Health and Information Tech Instl
MWOHX64.09N/A
N/A
MFS Global Growth R3
VMCCX53.19N/A
N/A
Virtus KAR Mid-Cap Core C